SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 4th, 2004 • Neurobiological Technologies Inc /Ca/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 4th, 2004 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 1, 2004 among Neurobiological Technologies, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, a “Purchaser” and collectively, the “Purchasers”).
Warrant No. [ ] Dated: March 1, 2004Neurobiological Technologies Inc /Ca/ • March 4th, 2004 • Biological products, (no disgnostic substances)
Company FiledMarch 4th, 2004 IndustryNeurobiological Technologies, Inc., a Delaware corporation (the “Company”), hereby certifies that, for value received, or its registered assigns (the “Holder”), is entitled to purchase from the Company up to a total of [ ] shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price equal to $6.73 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time and from time to time from and after the six month anniversary of the date hereof and through and including the date that is five years and six months from the date of issuance hereof (the “Expiration Date”), and subject to the following terms and conditions. This Warrant (this “Warrant”) is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers identif